Natural Killer (NK) cells have been implicated in the response to poxviruses, but the interaction between NK and infected cells is not well characterized. We show that downregulation of class I major histocompatibility complex (MHC-I) molecules in human cells by vaccinia virus (VV) sensitizes the cells to lysis by NK cells. We provide evidence suggesting that NK cells are infected as a consequence of co-culture with infected target cells. We also show that infection of NK cells leads to a marked depression of cytotoxicity. Moreover, the effect on NK cytotoxicity occurs within hours of infection and is prevented by UV inactivation of the virus but is only partially prevented by blocking late gene expression. VV infection also renders the NK cells more sensitive to inhibitory signals. Together our observations suggest that VV infection of NK cells can modulate their signaling in a manner that prevents them from acting on infected target cells.
Introduction
Tremendous insight into mechanisms of immune-evasion has been gained through studying vaccinia virus (VV). VV is a member of the orthopox genera of poxviruses. Poxviruses are large, enveloped, double-stranded DNA viruses that replicate entirely in the cytoplasm of host cells. Poxviral genomes generally encode upwards of 200 genes, roughly half of which are devoted to evading the host immune response. Immune evasion strategies encoded by poxviruses include proteins that interfere with aspects of the both the innate and adaptive immune response (reviewed in Seet et al., 2003) . Poxviruses block complement, cytokines, chemokines, as well as prevent apoptosis, antigen presentation and other intracellular signaling processes. Typically poxvirus infection occurs through exposure at the cutaneous layer or through mucus membranes (reviewed in Buller and Palumbo, 1991) . At these barriers, various innate leukocytes such as dendritic cells and natural killer (NK) cells provide a first line of defense against invading pathogens. Therefore, NK cells are among the targets of poxviruses to subvert the immune response.
NK cells are large granular lymphocytes known to contribute to the early immune response to viruses (Biron, 1997; Long et al., 1997) . NK cells possess innate cytolytic activity and can be further stimulated by cytokines such as IFN-a and h, IL-12 and IL-18 that are produced mainly by dendritic cells in response to viral infection. NK cells are also stimulated by direct interaction with dendritic cells and aid in stimulation of dendritic cells to instigate an adaptive immune response (Raulet, 2004) . Importantly, NK cells directly impede viral replication by lysis of infected cells through release of cytolytic granules or engagement of Fas receptors, as well as by secretion of antiviral cytokines such as IFN-g. NK cells are triggered by activating receptors which initiate intracellular signaling events through tyrosine kinases, ultimately resulting in polarized degranulation and cytokine secretion (Vivier et al., 2004) . There are several different NK activating receptors encoded within the natural cytotoxicity receptor complex located within the NK gene complex (reviewed in Moretta et al., 2001 ). There are NK activating receptors that specifically recognize infected cells, that bind to endogenous markers of cellular stress or bind to ligands thought to be constitutively expressed on healthy cells. For example, the human activating receptor NKp46 binds to viral hemagglutinins (Mandelboim et al., 2001) , and the murine activating receptor Ly49H binds to an MHC-I homologue encoded by MCMV (Arase et al., 2002) . However, NK cells determine their response based on integration of positive and negative stimuli they receive upon contact with potential target cells. The negative regulation of NK cells is through class I major histocompatibility complex (MHC-I) proteins, which are targeted by many viruses and tumors in order to evade T cell responses. To detect classical MHC-I molecules, human NK cells express inhibitory receptors belonging to the killer cell immunoglobulin-like receptor (KIR) family (Long, 1999) . The cytoplasmic tail of KIRs contains immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that provide the biochemical basis for inhibition through the recruitment of a tyrosine phosphatase, SHP-1 (Burshtyn et al., 1996 (Burshtyn et al., , 1999 .
There are several lines of evidence that NK cells play an important part in the defense against members of the orthopoxvirus genera. The resistance of certain mouse strains to ectromelia virus maps to the NK gene complex, containing genes involved in activation and regulation of NK cell responses (Delano and Brownstein, 1995) . Furthermore, depletion of NK cells with asialoGM1 renders mice more susceptible to VV (Bukowski et al., 1983) . VV is known to moderately downregulate MHC-I (Baraz et al., 1999; Boshkov et al., 1992; Brutkiewicz et al., 1992) , but whether or not the down regulation is sufficient to stimulate NK cells has not been well established for either human or mouse cells. The specific NK receptor responsible for VV recognition is unknown, but human NK cells exhibit increased lysis of VV-infected targets in vitro (Baraz et al., 1999) . Ectromelia virus encodes a protein p13 that antagonizes the function of IL-18 and thus indirectly interferes with activation of NK cells (Born et al., 2000) . Homologues of ectromelia p13 are encoded by VV, cowpox and molluscum contagiosum virus (Novick et al., 1999; Smith et al., 2000) . In addition, VV and ectromelia also encode soluble IFN-g receptors that block the action of IFN-g Smith, 1996a, 1996b) . These mechanisms serve to dampen the NK response indirectly without preventing the constitutive activity of NK cells to lyse target cells. In addition to the immune-evasion strategies that rely on secreted proteins that modulate innate immunity, VV can also directly infect several types of innate immune cells including dendritic cells resulting in blocking dendritic cell maturation into functional antigen presenting cells (Engelmayer et al., 1999) . Given that NK cells are among the first cells recruited to a site of viral infection and do not require activation by other cytokines to begin to lyse target cells, NK cells are an obvious target for viruses to modulate by direct infection. After encountering a potential target cell, NK cells make intimate contact with the target cell and then release their cytolytic granules. At a site of infection, NK cells intimately contacting a VV-infected target cell are likely exposed to VV possibly making them a target for VV infection. We and others have used VV as a vector for protein expression in NK cells indicating these cells are able to be infected by VV (Burshtyn et al., 1996; Paolini et al., 1999; Rajagopalan and Long, 2000; Ting et al., 1995; Wagtmann et al., 1995; Wei et al., 2000) ; however, infection of NK cells requires highly concentrated purified virus in the absence of serum. Therefore, we questioned whether NK cells could be infected in a more physiologic setting such as during contact with productively infected cells.
Here, we show that VV infection decreases MHC-I expression on target cells enough to prevent KIR-mediated protection of the target cell. More interestingly, we provide evidence suggesting that NK cells are subject to infection themselves during contact with VV producing target cells. We show that infection leads to a reduction in the cytolytic capacity of the NK cells. The implication of these results is that VV may modulate NK responses by infecting NK cells that enter the site of infection to render them less sensitive to VV-infected target cells.
Results

Downregulation of HLA-C by VV and KIR responses
To explore the possibility that downregulation of MHC-I induced by members of the orthopoxvirus genera may be sufficient to activate NK cells, we investigated if VV infection affects surface expression of human MHC-I and if the associated change was sufficient to influence KIR signaling. First, MHC-I expression was monitored following infection by flow cytometry using the pan reactive anti-HLA antibody W6/32. We compared expression of total MHC-I on the surface of HEK293T cells and Jurkat T cells, which express a full complement of MHC-I genes, namely HLA-A, B and C. As a positive control for a reduction in HLA expression, we blocked new protein synthesis with cycloheximide. The decreases in MHC-I expression after 8 h of infection are shown in Fig. 1 . NK cell recognition of target cells is regulated to a major extent by KIR recognition of HLA-C type molecules (Valiante et al., 1997) ; however, one previous report suggested that VV downregulates MHC-I expression but perhaps not HLA-C (Baraz et al., 1999) . Therefore, we examined downregulation of a subset of HLA-C alleles each recognized by a KIR molecule, namely HLACw4, HLA-Cw7 and HLA-Cw15 that were each stably expressed in the MHC-I-deficient B cell line, 721.221. We observed comparable loss of all HLA-C alleles (Fig. 1C) after VV infection. The loss of MHC-I expression following infection suggested that VV-infected target cells should become more sensitive to NK cells.
We next evaluated if our model NK line NK92 expressing KIR could detect the loss of MHC-I following infection by VV. NK92 and NK92 cells expressing KIR2DL3 cells were used in a cytolysis assay with 221-Cw7 target cells that were either mock infected or infected with VV (HLA-Cw7 is a ligand for KIR2DL3). Parental NK92 cells lysed 221-Cw7 cells, and this lysis is not altered in the presence of an antibody specific for KIR ( Fig. 2A, panel i) . Expression of KIR2DL3 in NK92 cells inhibits lysis of 221-Cw7 cells, and this protection is blocked by the presence of the anti-KIR Ab DX27 ( Fig. 2A, panel ii) . Following infection of the target cells, both NK92 and NK92-KIR2DL3 lyse the target cells similarly in the presence and absence of the anti-KIR antibody ( Fig. 2A , panels iii and iv).
Next, we generated NK clones from two healthy NK donors (see Materials and methods for details) and tested if these KIR2DL1 positive clones could also detect the loss of MHC-I following VV infection. We either mock infected or VV infected 221-Cw15 target cells (HLA-Cw15 is a ligand for KIR2DL1) and used these cells in a cytolysis assay with two KIR2DL1 positive clones in the presence or absence of anti-KIR blocking antibody HP-3E4 (Fig. 2B and data not shown). Following infection of the target cells, the KIR2DL1 positive NK clone is sensitive to the loss of MHC-I from the target cells. These observations suggest that the decrease in MHC-I following VV infection is sufficient to render infected cells more sensitive to lysis by NK cells.
NK cell infection
To establish whether NK cells could be infected when exposed to other cells infected with VV, we performed coculture experiments and compared infection to our established protocols for infecting NK cells directly with purified virus (Rajagopalan and Long, 2000) . To facilitate these experiments, we generated a recombinant VV strain WR that expresses the enhanced green fluorescent protein (EGFP) under the control of the synthetic early/late promoter and monitored the infection of the target cells by flow cytometry. We performed co-culture experiments with VV-EGFP infected monolayers of TK-cells incubated with NK cells on top of the infected monolayer. The amount of NK cell infection was compared to direct infection of NK cells with purified virus in the presence or absence of serum. Human NK cells were exposed for 4 h to infected monolayers or directly infected with purified VV-EGFP. After 4 h, the NK cells were gently removed and processed for flow cytometry using anti-LFA-1 antibody to distinguish NK cells from TKcells that may be included in the sample. Uninfected NK cells (mock) are LFA-1 positive and GFP negative (Fig. 3A , panels a -d). Over 50% of primary NK cells became EGFP positive by exposure to the infected monolayer (Fig. 3A,  panel i) . Importantly, the fraction of EGFP positive NK cells did not change in the presence of serum (Fig. 3A , panels i and k). This is in stark contrast to the NK cells infected with the purified virus (Fig. 3A , panels e and g). To control for non-specific transfer of EGFP to the NK cells, we included cycloheximide during the co-culture or infection. Cycloheximide prevented EGFP expression in NK cells directly infected or infected by co-culture (Fig. 3A , panels f, h, j and l). A quantitative depiction of the results with the human NK population cells is shown in Fig. 3B . As well, in similar experiments with NK92 cells, we observed that while NK92 cells are also infected during co-culture, the infection remains somewhat sensitive to the presence of serum (Fig.  3B ). To ensure that the NK cells are actually infected as opposed to simply having EGFP stuck to their external surfaces, we ''infected'' fixed NK cells by direct infection or performed co-culture with infected monolayers for 4 h. 
Replication of VV in NK cells
VV is known for its ability to infect a broad range of cell types, but infection of other innate immune cells such as macrophages and dendritic cells is non-productive (Broder et al., 1994; Engelmayer et al., 1999; Jenne et al., 2000; Natuk and Holowczak, 1985) . Therefore, we tested if VV WR replicated in NK92 cells or IL-2 activated human NK cells. As a positive control, the replication of the virus was measured in TK-cells. The VV associated with the cell pellet was released by 3 rounds of freeze/thaw and titered. Replication of VV in TK-cells was clear following infection at an MOI of 1, but no replication was detected for both the NK92 or primary NK cells (Fig. 4A) . However, by flow cytometry with the antibody VV-1, we determined that only a small fraction of the NK cells were infected after 4 h of VV infection at an MOI of 1 (data not shown). Therefore, we performed similar experiments at an MOI of 10 that achieves VV-1 staining in 90% of the cells, but replication was not obvious under these conditions either (Fig. 4A) .
Late viral gene expression in NK cells
To determine if VV infection in NK cells progresses to the point of late gene expression, we exploited the h-galactosidase expressed by our recombinant VV. h-Galactosidase expression in the pSC66 recombinant VV is driven by the p7.5 promoter that is a natural early/late promoter of moderate strength (Chakrabarti et al., 1997; Cochran et al., 1985) . We first assayed h-galactosidase activity using X-gal staining of the cells. Blue color was obvious for the NK92 cells, but the intensity of color in the primary NK cells was very faint. Western blots confirmed that there was greater expression of hgalactosidase in the NK92 cells compared to the primary NK Cr and cell lysis determined by the cells (Fig. 4B) , and a longer exposure of the western blot for the primary NK cells showed weak expression of h-galactosidase at 3 h (data not shown). However, for both types of cells, treatment with Ara-C decreased the expression even at 3 h postinfection (Fig. 4B ). These results imply that some replication of the viral DNA and concomitant expression of late genes occurs in these cells although this appears to be quite minimal for the primary NK cells. Therefore, while some late gene expression occurs, this does not lead to production of infectious virus, even in NK92 cells.
VV infection modulates NK cell function
To assess the effect of VV infection on the function of NK cells, we infected various primary IL-2 activated NK cells and NK92 with purified VV for 2 h and then determined the ability of these cells to lyse 721.221 target cells in a chromium release assay (Fig. 5A) . Infection reduced the effectiveness of both the NK92 cells and the IL-2 activated NK cells at all effector to target ratios examined, and this reduction was strengthened with increased duration of infection (data not shown). Exposure to UV-inactivated virus did not substantially affect the level of lysis by the NK cells indicating that active virus infection was necessary for NK cell inhibition of killing. To assess the contribution of late gene expression in reducing killing, we performed the assay in the presence of Ara-C which prevents replication of the DNA and subsequent production of late proteins (Fig. 5B) . Ara-C partially restored the ability of NK92 cells to lyse 721.221 cells that are devoid of MHC-I. The results also suggest that while late genes might be responsible for modulating the function of the NK cells, events that occur early during infection also modulate NK cytolytic activity. This is likely to be particularly true for the primary NK cells that only produce low levels of late proteins. To determine if any of the effect on NK cytotoxicity was an indirect consequence of VV interference with host protein synthesis, we blocked protein synthesis with cycloheximide. Cycloheximide alone had no effect on NK92 (Fig. 5B ) or primary NK cell lysis (data not shown) of the target cells. When we used the combination of cycloheximide and VV where both viral and host protein synthesis are shut down, we served an intermediate effect on the NK cytolytic activity. Together, these results suggest that infection with active virus is required to modulate NK cell cytotoxicity, and that both early and late events are responsible for decreasing cytotoxicity initiated by NK cells.
Infection renders NK92 cells more sensitive to inhibitory receptors
We previously observed that KIR-mediated inhibitory signals in NK92 cells appear more potent when KIR expression is driven by recombinant VV than when KIR is stably transfected into NK92 (Kirwan and Burshtyn, unpublished observations) . In view of our current findings that VV decreases NK cytolytic function, we postulated that infection with VV quickly tipped the balance of signaling towards inhibition, perhaps by interfering with the activation-signaling cascade. To test this hypothesis, we infected NK92 lines stably transfected with KIR with a recombinant virus that encodes h-galactosidase (VV-pSC66) and determined the effects of VV infection on KIR signaling. We first examined the effect of infection on signaling through KIR2DL3 when encountering target cells bearing the MHC-I allele, HLACw7. The transfectant expresses relative low levels of KIR and correspondingly results in a partial drop in lysis of MHC-I bearing target cells (Fig. 6A) . Following infection of these cells with VV-pSC66 (in the presence of Ara-C), there is a drop in cytotoxicity on both control cells and target cells expressing MHC-I. However, the drop in lysis is much more pronounced for the cells expressing the MHC-I (Fig. 6A) , suggesting that the infected NK cells are more sensitive to inhibition through KIR. Notably, the short infection also did not alter the level of KIR expression on the cell surface, while the cells are shown to be infected by VV-1 staining (Fig. 6B) .
We utilized an even more sensitive readout by assessing the very weak inhibitory signal provided by ITIM-deficient KIR through the inhibitory co-receptor ILT2 (Kirwan and Burshtyn, 2005) . These experiments were performed with a cell line expressing a truncated KIR fused to EGFP, TR-KIR-EGFP NK92 (Standeven et al., 2004) . The weak inhibition through KIR/ILT2 when engaged by MHC-I expression in 721.221 cells is barely detectable (Fig. 7) , although it is detected with target cells that express a higher density of ligand (Kirwan and Burshtyn, 2005) . Importantly, infection of these effector cells reveals the MHC-I specific inhibition as there is sensitivity to this fixed amount of inhibitory signal when the effector cells are VV infected (Fig. 7) . In addition, we tested if the increased sensitivity to inhibitory receptor signaling required active virus by comparing the effect of active and UV-inactivated virus. The UV-inactivated virus had no effect on signaling through the KIR-ILT2 pathway (Fig. 7A) . Again, since the threshold for activation or inhibition could be altered by perturbations of host proteins, we tested if the effect of infection on KIR signaling could be mimicked by a block in protein synthesis using the protein synthesis inhibitor emetine. While pretreatment of the NK92 cells with emetine clearly reduced synthesis of cellular proteins as did virus infection (Fig. 8A) , it did not augment the amount of inhibition observed by the KIR-ILT2 pathway (Fig. 8B) . These results suggest factors rapidly introduced by infection are responsible for increasing the sensitivity of NK cells to inhibition by inhibitory receptors.
Discussion
The loss of MHC-I expression from the cell surface following viral infection helps viruses evade cytotoxic T cells but renders them susceptible to NK cells. It has previously been shown that the window of vulnerability of VV-infected mouse cells to NK cell-mediated cytolysis is concomitant with a decrease in mouse MHC-I expression (Brutkiewicz et al., 1992) . The results presented here support a role for MHC-I loss in sensitizing VV-infected human cells to NK cells. Similar to what has been previously reported in primary human T cells (Baraz et al., 1999) , we observed MHC-I loss on HEK293 and Jurkat cells that presumably have a full complement of MHC-I molecules, HLA-A, B and C. The downregulation of HLA-C is pertinent because HLA-C is one of the major ligands for KIR, and in many individuals, a large fraction of their NK cells are regulated through HLA-C. We also observed a decrease of MHC-I expression for 221-Cw4, Cw7 and 221-Cw15 cells that only express HLA-C. Our results differ from those of Baraz et al. as they did not observe a loss of HLA-Cw3 from 221-Cw3 cells even 24 h after infection (Baraz et al., 1999) . Differences in our approaches may lead to different rates of infection that explain the discrepancy. Baraz et al. examined the cells 24 h after infection, a time at which we find most infected 721.221 cells are dead. To achieve near complete infection of the 721.221 derived cells, we used a higher dose of virus, performed the infection in serum-free conditions and established the majority of the cells were infected by flow cytometry using an antibody to a viral protein. MHC-I downregulation has been studied in depth for another poxvirus family member, myxoma, that downregulates MHC-I from the cell surface rapidly and very efficiently using the myxoma virus leukemiaassociated protein, MV-LAP/M153R (Boshkov et al., 1992; Guerin et al., 2002) which has homologues in herpesviruses and other poxviruses. However, VV does not contain a MV-LAP homologue, and therefore, whether or not VV possesses specific mechanisms to decrease MHC-I remains to be determined. MHC-I loss from the cell surface may simply be due to the welldescribed ability for VV to prevent transcription of host genes.
Even though the MHC-I decrease induced by VV is relatively moderate, the loss of MHC-I, and more specifically HLA-C, following VV infection may be important for sensitizing VV-infected cells to lysis by NK cells (Fig. 2A) . We have provided evidence to support this by showing that the loss of HLA-Cw7 after 14 h of VV infection is sufficient to abrogate signaling via KIR2DL3 in NK92 cells. We have also shown that after a 12-h VV infection of HLA-Cw15 target cells, human-derived KIR2DL1 positive NK clones are sensitive to the loss of HLA-C from infected target cells (Fig. 2B) . It should be noted that the latter experiment tests endogenous levels of high affinity KIR with a target cell line expressing very high levels of HLA-C (Fig. 1C) . A number of different strategies used by viruses to evade NK cells have been the topic of a recent review (Lodoen and Lanier, 2005) . Viruses that establish persistent infections often display potent MHC-I downregulation and concomitant strategies to evade attack by NK cells including decoy MHC-I-like proteins. However, there are examples of MHC-I homologues in various poxviruses such as molluscum contagiosum, swinepox virus and yaba-like disease virus that do not establish a persistent infection Senkevich and Moss, 1998) . However, no such molecules have been reported to date for VV or variola virus. These viruses possess alternative strategies to evade NK cells in addition to blocking factors such as IFN and IL-18 that serve to promote NK responses. Our results also suggest that despite the anti-apoptotic proteins encoded by VV strain WR that interfere with Granzyme B-mediated cell death (Dobbelstein and Shenk, 1996; Kettle et al., 1997; Wasilenko et al., 2003) , the infected cells remain susceptible to NKmediated lysis. The ability of NK cells to lyse VV infected cells may be due to the high levels of perforin secreted by these cells that may induce membrane damage directly or release of Granzyme M, a Granzyme that is highly expressed in NK cells including NK92 and not conventional T cells (Krenacs et al., 2003) . Granzyme M does not rely on the typical caspase cascade to induce cell death (Kelly et al., 2004) . A more detailed time course analysis of when and to what degree the target cells are susceptible to NK cells might be very interesting if, for example, the target cells are resistant until infectious intracellular mature virions (IMV) accumulate.
Our results suggest that NK cells are readily infected when they contact a monolayer of infected cells. It is interesting that we consistently observed higher rates of infection as measured by EGFP expression during co-culture of primary NK cells compared to the transformed line NK92. The reason for this difference is unknown but might be due to differences in how these cells interact with the infected cells, expression of receptors required for viral uptake or inactivation of viral particles/genomes once inside the cells. The ability of VV to infect NK cells could simply provide another niche for viral replication. However, despite the ability of purified virus to infect NK cells and evidence for some progression to the late phase of infection, we did not detect significant replication of VV in NK cells. One complication of performing these experiments is the possibility that once they are infected, the NK cells become victim to other NK cells in the culture. However, we did not observe viral replication even at high doses (MOI of 10) that quickly render the NK cells unable to efficiently kill target cells. Although replication in human NK cells cannot completely be ruled out, it seems unlikely to be significant based on our findings. The lack of replication of VV in NK cells is similar to that observed for other cells that are part of the innate immune system. Infection of macrophages and dendritic cells is abortive, expression of late proteins is difficult to detect and is accompanied by apoptosis (Broder et al., 1994; Engelmayer et al., 1999; Jenne et al., 2000; Natuk and Holowczak, 1985) . There are only a few other examples of viruses known to replicate in NK cells, such as HHV-6 and HIV (Chehimi et al., 1991; Lusso et al., 1993) . However, non-productive infection of cells of the immune system can be adventitious for a virus if the infection disrupts the immune response.
In this study, we show that infection of NK cells has serious consequences for the cytolytic function of the NK cells. The large loss in NK cytotoxicity that occurs within hours of infection with VV is a result of infection. While the precise mechanism by which VV affects the function of NK cells remains to be determined, we determined that both early and late gene products likely independently produce effects on NK cells' function because blocking late gene expression only partially restores the function of the NK cells. It is interesting that the combination of cycloheximide with VV infection restores the function of NK cells to a greater extent than Ara-C alone but not completely, suggesting that new VV protein synthesis may not be required for all of the consequences on the NK cell. When VV infects a cell, there are a number of virion associated proteins that are delivered into the cell. One candidate protein that may be affecting NK cytolysis is the dual-specific phosphatase VH1 that enters the cell with the virion (Liu et al., 1995) . VH1 has been shown to disrupt signaling cascades in a variety of cell types (Alonso et al., 2003; Liu et al., 1995; Najarro et al., 2001) . A role of VH1 in decreasing signaling could explain why UV inactivated virus has less of an effect than cycloheximide, as UV treatment blocks VH1 release from the virions (Najarro et al., 2001) . Coincidentally, new production of VH1 occurs late and could be blocked by Ara-C as well.
It is perhaps not surprising that NK functions such as target cell recognition, signaling and degranulation are disrupted by the infection with VV. As the infection progresses, much of the cellular machinery required for these functions such as the actin and microtubule cytoskeleton are taken over by the virus, and the morphology of cell is drastically altered. However, as many early genes are associated with immune-evasion, the mechanism by which early proteins dampen NK cytotoxicity may represent a more deliberate strategy of the virus to impede the function of NK cells.
The balance of the strength of the activating and inhibitory signals an NK cell receives determines if a potential target cell will be lysed or not. To maximize the sensitivity of NK cells to losses in MHC-I expression, the ideal KIR-MHC-I interaction would be just enough to prevent NK activation. In fact, the benefit of a low threshold for NK activation was recently implicated by the linkage of HCV resistance to individuals that express a KIR with relative low affinity for HLA-C (Freeman et al., 2005; Khakoo et al., 2004) . In relation to poxviruses, NK cells are likely most important to control viremia during the window following infection prior to formation of new virus, as lysis at later time points might simply facilitate viral dissemination. Using an NK cell line transfected with an inhibitory receptor specific for HLA-C (KIR2DL3) and NK clones, we observed that the early block of cytolysis after VV infection of NK cells also manifests as an enhanced inhibitory signal in response to HLA-C. These observations suggest that infection of NK cells provides a mechanism for the virus to rapidly block the function of NK cells by a process that includes sensitizing the NK cells to lower levels of class I molecules. The most likely scenario is that viral proteins antagonize the activation-signaling cascade which enhances sensitivity to KIR, as opposed to modifying the KIR signal itself. The physiologic importance of VV infection of human NK cells is understandably difficult to assess. However, it is interesting that the highly attenuated MVA strain (host restricted modified vaccinia virus Ankara) shows a reduction in infectivity of NK and B cells, but not monocytes, as the loss of NK infectivity could contribute to MVA attenuation (Sanchez-Puig et al., 2004) . There are other examples of viruses infecting NK cells such as EBV (Isobe et al., 2004) , HIV (Chehimi et al., 1991) and HHV-6 (Lusso et al., 1993) , but to our knowledge, this is the first example of NK function being so dramatically affected by infection so quickly. Given that NK cells are exposed when they interact with virus producing target cells, it is likely that NK cells that enter a site of infection are inactivated by this process.
Materials and methods
Antibodies and inhibitors
Monoclonal antibodies DX27 specific for KIR2DL3 (IgG2a, DNAX), W6/32 a pan-HLA Ab (IgG2a, ATCC HB-95), anti-LFA-1 alpha (IgG1, ATCC HB-202) and anti-CD8 51.1 (IgG2a, HB230 ATCC) were purified from culture supernatants using protein A or G sepharose. The antibodies were dialyzed into phosphate-buffered saline (PBS) and filter sterilized for use in functional assays. Monoclonal antibody EB6 specific for KIR2DL1/S1 (IgG1) was purchased from Beckman Coulter Immunotech (Mississauga, Canada). AntiCD158a clone HP-3E4 (IgM) ascites was provided by Dr. E. Long (Melero et al., 1994) . Clarified MOPC-104E ascites (control IgM) was purchased from Sigma-Aldrich. The antibody VV-1-1G10-1-1 (VV-1), specific for VV A33R, was a gift from Dr. Schmaljohn (Fort Dietrick, MD) (Hooper et al., 2000) . FITC-and PE-conjugated goat anti-mouse IgG were purchased from Cedarlane (Hornby, Canada). Rabbit polyclonal ab616 anti-h-galactosidase antibody (IgG) was purchased from abcam (Cambridge MA).
Cycloheximide (ICN Biomedicals) was dissolved in H 2 O, used at a final concentration of 100 Ag/ml and maintained throughout the experiments. Emetine-HCl (EMT, Sigma Chemical Company) was dissolved in Iscoves medium and used at a final concentration of 5 Ag/ml for 2 h and then washed out. Cells were fixed in 2% formaldehyde (Sigma Chemical Company) in PBS for 20 min at room temperature.
Cells
The NK92 cells, a non-Hodgkin's lymphoma line devoid of KIR or Fc receptors, were obtained from ATCC (CRL-2407) (Gong et al., 1994) . NK92 cells were cultured in either Iscoves medium containing 50% Myelocult H5100 (Stem Cell Technologies) and 7.5% Fetal Bovine Serum (FBS) (Hyclone) or aMEM medium with 12.5% FBS and 12.5% horse serum (Invitrogen), supplemented with 25 AM 2-mercaptoethanol and 1 mM l-glutamine (Invitrogen) and 100 U/ml human recombinant IL-2 (TECIN, obtained from the Biological Resources Branch, DCTC, NCI-Frederick Cancer Research and Development Center). NK92 cells stably expressing various KIR molecules were cultured in the same medium with the addition of 0.5 mg/ml geneticin (Invitrogen). NK92 expressing the truncated KIR2DL1-EGFP chimera (TR KIR-GFP) have been previously described (Standeven et al., 2004) . The cDNA encoding KIR2DL3 was subcloned using the restriction enzymes Xho I and Xba I into the plasmid BSRaEN (provided by Kevin Kane, University of Alberta). NK92 cells were electroporated, as previously described (Standeven et al., 2004) . Geneticin resistant lines were propagated, screened for expression by flow cytometry and subcloned to establish lines with stable levels of expression.
The collection of blood and related experimentation was approved by the Health Research Ethics Board at the University of Alberta. Primary human NK cells were isolated from whole blood by magnetic separation using StemSep (Stem Cell Technologies). Isolated NK cells (both NK population and NK clones plated at one NK cell per well) were grown on irradiated 721.221 feeder cells in the presence of 200 U/ml IL-2 and were maintained in culture for up to 6 weeks.
The MHC-I negative transformed B cell line 721.221 cells were maintained in Iscoves medium with 10% FBS (Invitrogen) and 2 mM l-glutamine. The 721.221 transfected cell lines 221-Cw3, 221-Cw4, 221-Cw7 and 221-Cw15 cells were obtained from Peter Parham (Stanford University) and maintained in 0.5 mg/ml geneticin. HEK293T cells were grown in DMEM medium (Invitrogen), 10% FBS, 10 mM HEPES (Fisher) and 2 mM l-glutamine. Jurkat T cells were grown in RPMI medium supplemented with 10% FBS, 25 AM 2-ME, 2 mM l-glutamine. Thymidine kinase-deficient human osteosarcoma cell line 143B (ATCC #8303), herein referred to as TK-cells, was grown in DMEM, 10% FBS, 10 mM HEPES and 2 mM l-glutamine.
Recombinant vaccinia viruses and infection
Enhanced green fluorescent protein (EGFP) was subcloned into the plasmid pSC66 using the sites Sal I and Not I and recombined into the TK locus of VV WR as previously described to generate VV-EGFP (Mackett et al., 1984) . VV strain WR, VV-pSC66 (Kirwan and Burshtyn, 2005) or VV-EGFP was purified on sucrose gradients or semi-purified. Briefly, for semi-purification, the virus was amplified in TK-cells, released from the cells by sonication and enriched by spinning through a 36% sucrose cushion. The titers of plaque-forming units/ml (PFU/ml) were determined on TK-cells.
NK92 or primary NK cells were washed twice in Iscoves medium supplemented with 2 mM l-glutamine, 0.1 mM nonessential amino acids (Invitrogen), 0.2% Bovine Serum Albumin (Boehringer Mannheim) and 100 U/ml rIL-2 (herein referred to as NK infection medium). Generally, 5 Â 10 5 to 4 Â 10 6 NK cells were resuspended in NK infection media (between 150 and 350 Al) and infected at the indicated multiplicity of infection (MOI) with purified VV for 2 h at 37 -C with 5% CO 2 . The cells were washed once with assay medium (5% FBS/Iscoves/2 mM l-glutamine/10 Ag/ml gentamicin), counted and diluted for plating in the cytolysis assays. Where indicated, experiments were carried out in the presence of cytosine h-d-arabinofuranoside-HCl (Ara-C) (Sigma Chemical Company) at a final concentration of 40 Ag/ml. When necessary, VV was UV inactivated for 1 min with a UV Stratalinker 2400 (Stratagene) or under a laminar flow hood UV-lamp for 45 min. For the infection of fixed NK cells, NK92 or human-derived NK cells were fixed in 2% formaldehyde for 20 min, then washed into NK infection media and infected at an MOI of 10 for 4 h with VV-EGFP. Infected NK cells were quantified by flow cytometry based on EGFP.
For MHC-I downregulation experiments, 1 Â 10 6 293T/17 cells were plated in 35-mm dishes in complete medium. Eighteen hours later, the cells were washed with infection medium and either treated with 100 Ag/ml cycloheximide or infected at an MOI of 10 with VV-pSC66 for 2 h and switched to complete medium. At 8 h, the cells were harvested with PBS/1 mM EDTA. Infection was quantified by X-gal staining. MHC-I expression was determined by flow cytometry using the antibody W6/32 followed by PE-goat anti-mouse IgG. Jurkat and 721.221 transfectants (5 Â 10 5 cells in 0.1 ml) were infected at an MOI of 10 with VV-WR virus in the same manner as the NK cells for 1 h and then supplemented with complete medium for the remaining 7 h. The sample was washed and divided into two and stained with either VV-1 or W6/32 followed by PE-goat anti-mouse IgG. Analysis of the expression of surface proteins was performed by flow cytometry.
Cytolysis assays
Target cells (0.5 -1 Â 10 6 ) were labeled with¨10 ACi 51 Cr (Sodium Chromate, NEN) for 1 h at 37 -C in 5% CO 2 . The targets were washed, diluted in assay medium and plated at 2500 cells per well in V-bottom microtiter plates in triplicate. The NK effector cells were pretreated (as indicated in the figure legends), washed once, counted and diluted to the appropriate concentrations in assay medium with 100 U/ml rIL-2. For antibody blocking experiments, NK cells were pre-incubated in twice the final concentration of antibody for at least 10 min at room temperature. Assays were incubated at 37 -C in 5% CO 2 for 4 h. The released chromium was quantified for 50 Al of supernatant and analyzed in a 1450 Microbeta Trilux (Wallac).
The specific lysis was calculated as 100Â (mean sample release À mean spontaneous release)/(mean total release À mean spontaneous release). The error bars represent the standard deviation of the mean for each triplicate.
Infection of NK cells by co-culture with infected monolayers TK-cells were plated at 5 Â 10 5 cells in a 35-mm dish for 22 h and then infected with VV-EGFP at a MOI of 3, and incubated for 16 h before addition of NK cells. NK92, primary NK cells, or formaldehyde fixed NK cells were washed twice in NK infection medium and resuspended at 1 Â 10 6 cells/ml. 1 Â 10 6 NK cells were overlayed onto the infected TK-cells in NK infection medium and cultured for 4 h. As a positive control, NK92 and primary NK populations were infected with semi-pure EGFP-VV with the same treatments. All cells were harvested with 2 washes of PBS/1 mM EDTA and resuspended in FACS buffer (PBS/ 1% FBS/1 mM EDTA). The cells were stained with anti-LFA-1 and PE-coupled secondary antibody. The percent of infected NK cells was quantified by flow cytometry based on EGFP and LFA-1 markers.
Replication of VV and b-gal expression in NK cells
NK92 and human-derived NK cells were washed twice with NK infection medium and resuspended in NK cell infection medium at 5 Â 10 6 cells/ml. For each point, 5 Â 10 5 NK cells were infected in suspension at the indicated MOI. TK-cells were plated at 5 Â 10 5 cells in a 35-mm dish for 20 h and then infected with VV-pSC66 at a MOI of 1. At time 0 or after 1 h of infection, the NK cells were washed once in PBS/1 mM EDTA, the appropriate complete medium was added, and the NK cell samples were then grown in suspension. The TK-cells were cultured in the 35-mm dishes, and cells were scraped off at indicated time points, and the wells were washed with PBS/1 mM EDTA. The infection was terminated by pelleting the cells, resuspending in 1.2 ml of DMEM medium with 2% FBS and frozen at À80 -C. When all samples were collected, the virus was released by 3 rounds of freezing and thawing and sonication. The samples were titered on TK-monolayers.
For h-gal expression, NK cells were infected as above, and at the indicated time points, the cells were lysed in 100 Al 1% Triton-X100. Samples were run out on 8% SDS-PAGE, transferred to Immobilon-P transfer membranes (Millipore) and probed for h-galactosidase with ab616 antibody.
Metabolic labeling
NK92 cells were washed twice in infection medium, followed by washing in methionine free DMEM medium (Invitrogen). The cells were then treated with indicated amount of cycloheximide or emetine or infected with VV-pSC66 for 2 h at 37 -C. After 2 h, the cells were incubated with 150 ACi 35 S-methionine (ICN Biomed) for 15 min, washed with cold PBS and lysed in lysis buffer (1% Triton w/v, 0.15 M NaCl, 20 mM Tris pH 8) containing Complete protease inhibitor cocktail (Roche). Nuclei and cell debris were removed by centrifugation at (20,000 Â g) for 15 min at 4 -C. Samples were separated by SDS-PAGE under reducing conditions and the labeled proteins detected by autoradiography.
Note added in proof
It has come to our attention that emetine is reversible under certain conditions and that 4 h post emetine treatment NK92 cells they synthesize protein at levels similar to untreated cells (J. Smiley & G. Zahariadis, personal communication). Therefore, the results in Fig. 8 depict a complete block of protein synthesis for the 2 h pretreatment and questionable block during the cytolysis assay itself.
